FI972090L - Antibakteeriset dibentsimidatsolijohdannaiset - Google Patents

Antibakteeriset dibentsimidatsolijohdannaiset Download PDF

Info

Publication number
FI972090L
FI972090L FI972090A FI972090A FI972090L FI 972090 L FI972090 L FI 972090L FI 972090 A FI972090 A FI 972090A FI 972090 A FI972090 A FI 972090A FI 972090 L FI972090 L FI 972090L
Authority
FI
Finland
Prior art keywords
antibacterial
dibenzimidazole derivatives
dibenzimidazole
derivatives
antibacterial dibenzimidazole
Prior art date
Application number
FI972090A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972090A0 (fi
FI972090A7 (fi
Inventor
Walter Haesler
Yu-Hua Ji
Werner Leupin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI972090L publication Critical patent/FI972090L/fi
Publication of FI972090A0 publication Critical patent/FI972090A0/fi
Publication of FI972090A7 publication Critical patent/FI972090A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI972090A 1994-11-17 1995-11-02 Antibakteeriset dibentsimidatsolijohdannaiset FI972090A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH345994 1994-11-17
PCT/CH1995/000255 WO1996016042A1 (de) 1994-11-17 1995-11-02 Antibakterielle dibenzimidazol-derivate

Publications (3)

Publication Number Publication Date
FI972090L true FI972090L (fi) 1997-05-15
FI972090A0 FI972090A0 (fi) 1997-05-15
FI972090A7 FI972090A7 (fi) 1997-05-15

Family

ID=4256402

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972090A FI972090A7 (fi) 1994-11-17 1995-11-02 Antibakteeriset dibentsimidatsolijohdannaiset

Country Status (9)

Country Link
US (1) US5824698A (de)
EP (1) EP0793654A1 (de)
JP (1) JPH09512831A (de)
AU (1) AU3696495A (de)
BR (1) BR9509671C1 (de)
CA (1) CA2204639A1 (de)
FI (1) FI972090A7 (de)
MX (1) MX9703634A (de)
WO (1) WO1996016042A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2150274C1 (ru) * 1996-12-26 2000-06-10 Бачин Игорь Валентинович Стабилизированная водорастворимая композиция трийодида 1,2,3-триалкилбензимидазолия
RU2135476C1 (ru) * 1998-12-07 1999-08-27 Ливицкий Василий Иванович Дийодбромиды 1,2,3-замещенных бензимидазолия и их водорастворимая композиция
GB9908828D0 (en) * 1999-04-16 1999-06-16 Univ Reading The Compounds
CA2371728C (en) * 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
EP1390081A2 (de) * 2001-01-08 2004-02-25 Neorx Corporation Therapeutische und diagnostische verbindungen, zusammenstellungen und methoden
US7701130B2 (en) 2001-08-24 2010-04-20 Semiconductor Energy Laboratory Co., Ltd. Luminous device with conductive film
WO2003051403A1 (en) 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
KR100629060B1 (ko) * 2004-08-11 2006-09-26 주식회사 엘지화학 새로운 벤즈이미다졸계 화합물
DE102005017508A1 (de) * 2005-04-15 2006-10-19 Basf Ag Verfahren zur Gewinnung einer basischen Aminosäure aus einer Fermentationsbrühe II
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
GB2480814A (en) * 2010-06-01 2011-12-07 Summit Corp Plc Compounds for the treatment of clostridium difficile-associated disease
SI2575968T1 (sl) 2010-06-01 2016-06-30 Summit Therapeutics Plc Spojine za zdravljenje bolezni, ki je povezana s clostridium difficile
GB2480813A (en) * 2010-06-01 2011-12-07 Summit Corp Plc Compounds for the treatment of clostridium difficile-associated disease
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
US20180000793A1 (en) 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
EP3999502A1 (de) 2019-07-17 2022-05-25 Summit (Oxford) Limited Verfahren zur herstellung von ridinilazol und kristallinen formen davon
GB202100470D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds
US12220421B2 (en) 2021-09-09 2025-02-11 The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Inhibitors of C. difficile spore germination

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087409A (en) * 1966-11-07 1978-05-02 Monsanto Company Ordered heterocyclic copolymers
US3484407A (en) * 1967-01-13 1969-12-16 Monsanto Co Linear condensation polymers containing carbonamide and heterocyclic linkages
US3592821A (en) * 1968-05-21 1971-07-13 Ciba Ltd 2-(2'-hydroxy-3',5'-dichlorophenyl)-5-chloro- or 5-methylbenzimidazoles
US4665066A (en) * 1984-12-24 1987-05-12 Eli Lilly And Company 3-thiazolomethyl cephalosporins as antibiotics
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5412059A (en) * 1993-04-05 1995-05-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Polybenzimidazoles via aromatic nucleophilic displacement

Also Published As

Publication number Publication date
BR9509671A (pt) 1997-10-28
FI972090A0 (fi) 1997-05-15
CA2204639A1 (en) 1996-05-30
WO1996016042A1 (de) 1996-05-30
BR9509671C1 (pt) 2000-04-18
AU3696495A (en) 1996-06-17
EP0793654A1 (de) 1997-09-10
MX9703634A (es) 1997-08-30
US5824698A (en) 1998-10-20
FI972090A7 (fi) 1997-05-15
JPH09512831A (ja) 1997-12-22

Similar Documents

Publication Publication Date Title
FI972090A7 (fi) Antibakteeriset dibentsimidatsolijohdannaiset
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
EP0708091A3 (de) Indoloylguanidin-Derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
PT824535E (pt) Cefalosporinas antibacterianas
BR9509793A (pt) Derivados de tiofeneno
NO990463D0 (no) Azabicykliske karbamoyloksymutilinderivater for antibakteriell anvendelse
FI971227A7 (fi) Pyramidinyylipyratsolijohdannaisia
DE69524611D1 (de) Pyrimidon-derivate
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
DE69529799D1 (de) Aminocyclopentan-Derivate
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853L (fi) Deasetoksitaksolijohdannaiset
NO992526D0 (no) Cephalosporin-derivater
FI973500A7 (fi) 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset
BR9506618A (pt) Derivados de difeniloxazolinas
DE69510792D1 (de) Naphtochinonderivate
FI955026L (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
DE69515498D1 (de) Naphthyridinderivate
FI963122L (fi) Karbamoyylimetyyliureajohdannaiset
KR960013362A (ko) 항균제
BR9506613A (pt) Derivados de feniltio-oxazolinas